# Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer

> **NCT00244920** · PHASE2 · WITHDRAWN · sponsor: **OHSU Knight Cancer Institute**

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** bicalutamide
- **DRUG:** leuprolide acetate
- **DRUG:** squalamine lactate
- **PROCEDURE:** adjuvant therapy
- **PROCEDURE:** antiandrogen therapy
- **PROCEDURE:** antiangiogenesis therapy
- **PROCEDURE:** conventional surgery
- **PROCEDURE:** neoadjuvant therapy
- **PROCEDURE:** releasing hormone agonist therapy

## Key facts

- **NCT ID:** NCT00244920
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2002-01
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor withdrew drug.
- **Last updated:** 2012-05-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00244920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00244920, "Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00244920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*